SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on September 14, 2020. The registrant is a Delaware corporation with principal executive offices in Carlsbad, California. The filing serves as a Regulation FD disclosure regarding management's participation in the H.C. Wainwright 22nd Annual Global Investment Conference.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a presentation event rather than a financial results report.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces the dissemination of a slide presentation to analysts and investors.
Guidance, Outlook, and Management Commentary
- Event: Management participated in the H.C. Wainwright 22nd Annual Global Investment Conference from September 14 through September 16, 2020.
- Content: Management referred to a slide presentation during separate sessions with analysts and investors.
- Exhibit: The slide presentation is attached as Exhibit 99.1.
- Legal Status: The information in this report and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the attached Exhibit 99.1 (Presentation dated September 14, 2020) for specific financial guidance or operational updates, as the 8-K text itself contains no data.
- Confirm the company name is Ra Medical Systems, Inc. (RMED), as the input metadata incorrectly referenced "Catheter Precision, Inc."
- Note that the presentation materials are not legally "filed" for liability purposes under Section 18 of the Exchange Act.